Back to News
Market Impact: 0.3
Boston Scientific Corporation Reports Third Quarter 2026 Results
Source: Nasdaq
Corporate EarningsCompany Fundamentals
Boston Scientific reported third-quarter 2026 net sales of $5.138 billion, up 1.5% year over year on a reported, operational and organic basis. The provided article text cuts off during the GAAP net income figure, so no earnings or expectation comparison is available.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.20
Ticker Sentiment
BSX0.20
More News
- Stock Movers:Vertiv, GE Healthcare, Boston Scientific (Podcast)
- Stock Market Today, Oct. 28: Boston Scientific Slips 6% After Cutting Q4 Sales and Full-Year EPS Guidance on Cyberattack Impact
- What investors need to know about Alphabet's stock-busting earnings report
- Our next steps for Alphabet stock after earnings disappoint at nearly every turn
- SK Hynix says the memory-chip shortage will last until 2030—and more than half its production is booked for the next two years
- China’s tech darlings are losing their shine. Here’s what’s behind the sell-off